Status:

COMPLETED

Effect of Levodopa on Postural Motor Learning in Parkinson Disease

Lead Sponsor:

VA Office of Research and Development

Collaborating Sponsors:

Oregon Health and Science University

Conditions:

Parkinson Disease

Eligibility:

All Genders

18-90 years

Brief Summary

The primary goal of this project is to gain a better understanding of whether and how levodopa (a common anti-Parkinson disease medication) alters postural motor learning in people with Parkinson dise...

Eligibility Criteria

Inclusion

  • Between 18 and 90 years of age.
  • Individuals with Parkinson Disease
  • Healthy adults age-matched to PD participants
  • Participants with PD will be currently taking dopamine replacement (i.e. Levodopa)

Exclusion

  • All subjects exclusion criteria:
  • Deep brain stimulation
  • Recent (within 6 months) orthopedic injuries influencing standing or balance
  • Inability to stand independently
  • Transcranial magnetic stimulation exclusion criteria (for the subset of individuals taking part in the Transcranial Magnetic Stimulation portion of the study):
  • History of epilepsy or currently taking any epileptic medication,
  • History of seizures
  • Family history of epilepsy or seizures

Key Trial Info

Start Date :

August 1 2014

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

September 1 2016

Estimated Enrollment :

42 Patients enrolled

Trial Details

Trial ID

NCT02239978

Start Date

August 1 2014

End Date

September 1 2016

Last Update

February 23 2017

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Oregon Health & Science University

Portland, Oregon, United States, 97210

2

VA Portland Health Care System, Portland, OR

Portland, Oregon, United States, 97239

3

VA Salt Lake City Health Care System, Salt Lake City, UT

Salt Lake City, Utah, United States, 84148